Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Florian Clatot
Kinetics, Prognostic and Predictive Values of ESR1 Circulating Mutations in Metastatic Breast Cancer Patients Progressing on Aromatase Inhibitor
Oncotarget
Oncology
Related publications
The Emerging Role of ESR1 Mutations in Luminal Breast Cancer as a Prognostic and Predictive Biomarker of Response to Endocrine Therapy
Cancers
Cancer Research
Oncology
Guidelines for Osteoprotection in Breast Cancer Patients on an Aromatase Inhibitor
Breast Care
Surgery
Oncology
Unraveling the Clinicopathological Features Driving the Emergence of ESR1 Mutations in Metastatic Breast Cancer
npj Breast Cancer
Oncology
Radiology
Nuclear Medicine
Pharmacology
Imaging
Analysis of ESR1 Mutation in Circulating Tumor DNA Demonstrates Evolution During Therapy for Metastatic Breast Cancer
Science Translational Medicine
Medicine
Prognostic Markers and Tumour Growth Kinetics in Melanoma Patients Progressing on Vemurafenib
Melanoma Research
Dermatology
Cancer Research
Oncology
Establishment and Validation of Circulating Tumor Cell-Based Prognostic Nomograms in First-Line Metastatic Breast Cancer Patients
Clinical Cancer Research
Cancer Research
Oncology
Prognostic and Predictive Values of the Immunoscore in Patients With Rectal Cancer
Clinical Cancer Research
Cancer Research
Oncology
Accumulation of P53 Is Prognostic for Aromatase Inhibitor Resistance in Early-Stage Postmenopausal Patients With ER-positive Breast Cancer
OncoTargets and Therapy
Oncology
Pharmacology
An 8-Gene mRNA Expression Profile in Circulating Tumor Cells Predicts Response to Aromatase Inhibitors in Metastatic Breast Cancer Patients
BMC Cancer
Cancer Research
Oncology
Genetics